Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GelSURE is a medical technology company specializing in the development of advanced hydrogel solutions for endoscopic procedures. The company's core technology is a thermally sensitive hydrogel that remains in a liquid state at room temperature but transforms into a viscous gel at body temperature. This provides a superior, long-lasting lifting cushion for endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), facilitating the removal of gastrointestinal lesions and polyps. Originally founded as a spin-out from the University of Nottingham, GelSURE was acquired by US Endoscopy, a subsidiary of STERIS, in 2012. The technology is now a key component of STERIS's gastrointestinal surgical portfolio, recognized for improving procedural efficiency and safety in complex endoscopic cases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GelSURE.